Sequana Medical NV

The end of 2022 brought good news for Sequana Medical . The company, which is simultaneously developing two products to treat fluid overload in the body, announced results from studies of both. In th

New drugs and devices appear to follow a similar path to market – an idea is formed, or a discovery is made, and then is developed into a product following regulatory approval. But the differences bet

Venture capital investors showed biopharmaceutical start-ups and growth-stage private companies some love with a trio of $100m-plus financings announced on 14 and 16 February, including a $236m series

European investment group LSP has raised $600m for a new fund to invest in medical device and other life sciences companies. LSP 6 is the group’s largest fund to date and said to be the biggest one in